Healthcare -
Biotechnology - NASDAQ - US
$ 0.7352
-3.14 %
$ 40.5 M
Market Cap
-0.42
P/E
PRLD - COST OF REVENUE
Cost of Revenue PRLD - Prelude Therapeutics Incorporated
1.17 M
LAST VALUE
-27.81%
2 YEAR CAGR
50.98%
5 YEAR CAGR
0.00%
10 YEAR CAGR